Chronic obstructive pulmonary disease and cytokines
Related Experiment Video
Updated: Jun 30, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
1Georgetown University School of Nursing & Health Studies, Washington, District of Colombia 20057, USA. angerioa@georgetown.edu
Abstract:
Chronic obstructive pulmonary disease is a leading cause of morbidity and mortality. Understanding what happens at a cellular level will lead to more effective treatments. Interleukins and transforming growth factor-beta are important inflammatory mediators that may be significant in the evolution of chronic obstructive pulmonary disease.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: